FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
   

Newsletter Home

Newsletter Index
Newsletter Issues
Newsletter Fact Sheet
Subscribe to the Newsletter

Index to Drug-Specific Information

MedWatch: The FDA Safety Information and Adverse Event Reporting Program
MedWatch 2008 Safety Alerts
Voluntary Reporting to MedWatch

Adverse Event Reporting System (AERS)

Email Us
Call Us
1-888-INFO-FDA
(1-888-463-6332) or
(301) 827-4570
 
Newsletter Index, Volume 2, 2009
A B C D E F G H I J K L M
N O P Q R S T U V W X Y Z

An index to brand-name drugs, generic drugs and health issues discussed in Drug Safety Newsletter articles. A list of drug safety alerts and communications can be found on the Index to Drug-Specific Information.

Newsletter Index, Volume 1, 2007-2008

Page numbers refer to the print version (PDF).


A
Abacavir, 5-6
Atomoxetine, 7-9
ADHD, 7-9



B
Bupropion, 1-4



C
Chantix, 1-4



E
Epzicom, 5-6



H
Hepatotoxicity, 7-9
HLA-B*570, 5-6
Hypersensitivity Reaction, 5-6



N
Nicotine, 1-4



S
Skin Patch Testing, 5-6
Strattera, 7-9
Suicide, 1-4



T
Trizivir, 5-6



V
Varenicline, 1-4



Z
Ziagen, 5-6
Zyban, 1-4

horizonal rule
   
horizonal rule